Frontlight ResearchEarly access
Taking people in FinlandPhase 4
Studies how prostate medicines affect gut bacteria in men
Tests whether prostate medicines change gut bacteria in adults with prostate conditions.
Key facts
- Who runs it
- Turku University Central Hospital
- Where
- Turku, FinlandSee the site
- Trial code
- Registry title
- Prostate medication, metabolism and gut microbiota, PROMED.
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 100 people, planned
- Started
- 1 Dec 2022
- Expected to end
- 31 May 2027
- Type of study
- Interventional
- Record updated
- 4 October 2022
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men over 18 with prostate cancer or benign prostate hyperplasia. It studies how prostate medicines affect the gut bacteria.
- Age
- Over 18 years
- Sex
- Men only
- Disease stage
- Prostate cancer or benign prostate hyperplasia, confirmed by tissue examination.
Main reasons for not taking part
- Cannot follow the study procedures or does not want to take part
- Under 18 years of age
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- histologically confirmed prostate cancer or benign prostate hyperplasia
- provision of signed and dated informed consent form
- ability and stated willingness to comply with all study procedures and availablity for the duration of the study
- male aged >18 years
Who cannot take part
- age < 18 years
- inability to comply with study procedures or unwillingness to participate in the study
Where in Finland
- Turku University Central HospitalTurku, FinlandTaking people
About the trial
What the trial wants to find out
The general aim is to understand the interaction of prostate medical therapies and gut microbiota. Main objective is to investigate how prostate medical therapies (5-ARI, ADT) affect gut microbiota composition.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- Prostate medication, metabolism and gut microbiota, PROMED.
- Plain-language title
- Studies how prostate medicines affect gut bacteria in menGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 4 October 2022